Week 3-4: Accelerated healing Mid-protocol effects often include noticeable functional improvement at injury sites, increased range of motion, reduced reliance on pain management, and visible changes in chronic injury conditions
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
These effects promote angiogenesis, fibroblast activity, and neuromuscular stabilization, particularly in poorly vascularized tissues such as tendons and myotendinous junctions
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice, investigated primarily for its regenerative and tissue-healing properties
More Than Nostalgia Alone What makes this collaboration feel different is that it does not rely only on memories from the past
doi: 10.1007/s00415-010-5726-x 49 DiackA
